Die interventionelle Therapie der Mitralklappeninsuffizienz

M. Seiffert; L. Conradi; H. Reichenspurner; H. Treede

doi:10.1007/s00398-011-0876-4

Die interventionelle Therapie der Mitralklappeninsuffizienz

Standard

Die interventionelle Therapie der Mitralklappeninsuffizienz. / Seiffert, M.; Conradi, L.; Reichenspurner, H.; Treede, H.

In: Z HERZ THORAX GEFASS, Vol. 25, No. 5, 10.2011, p. 258-265.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Seiffert, M, Conradi, L , Reichenspurner, H & Treede, H 2011, 'Die interventionelle Therapie der Mitralklappeninsuffizienz', Z HERZ THORAX GEFASS, vol. 25, no. 5, pp. 258-265. https://doi.org/10.1007/s00398-011-0876-4

APA

Seiffert, M., Conradi, L., Reichenspurner, H., & Treede, H. (2011). Die interventionelle Therapie der Mitralklappeninsuffizienz. Z HERZ THORAX GEFASS, 25(5), 258-265. https://doi.org/10.1007/s00398-011-0876-4

Vancouver

Seiffert M, Conradi L , Reichenspurner H , Treede H. Die interventionelle Therapie der Mitralklappeninsuffizienz. Z HERZ THORAX GEFASS. 2011 Oct;25(5):258-265. https://doi.org/10.1007/s00398-011-0876-4

Bibtex

@article{9859643add4f4fd58a4e00a4cd80f294,

title = "Die interventionelle Therapie der Mitralklappeninsuffizienz",

abstract = "Surgical mitral valve repair remains the gold standard treatment for significant mitral regurgitation achieving excellent results especially in degenerative mitral valve disease. Due to comorbidities and high surgical risk, a substantial number of patients are left untreated. It is especially for these patients that interventional and less invasive devices need to be explored. Most of the currently investigated technologies mimic surgical methods of valvuloplasty, annuloplasty, and valve replacement. Edge-to-edge repair with the MitraClip{\textregistered} device imitates the Alfieri stitch and obtained encouraging results in a randomized trial compared with surgical mitral valve repair. Due to its high safety profile, this approach can already be seen as complimentary to surgery for patients with functional mitral regurgitation and poor left ventricular function. A close interdisciplinary collaboration of cardiologists and cardiac surgeons is essential for a successful interventional mitral valve program.",

keywords = "Minimally invasive surgical procedures, Mitral valve, Percutaneous, Safety profile, Transcatheter",

author = "M. Seiffert and L. Conradi and H. Reichenspurner and H. Treede",

year = "2011",

month = oct,

doi = "10.1007/s00398-011-0876-4",

language = "Deutsch",

volume = "25",

pages = "258--265",

journal = "Z HERZ THORAX GEFASS",

issn = "0930-9225",

publisher = "Springer",

number = "5",

}

RIS

TY - JOUR

T1 - Die interventionelle Therapie der Mitralklappeninsuffizienz

AU - Seiffert, M.

AU - Conradi, L.

AU - Reichenspurner, H.

AU - Treede, H.

PY - 2011/10

Y1 - 2011/10

N2 - Surgical mitral valve repair remains the gold standard treatment for significant mitral regurgitation achieving excellent results especially in degenerative mitral valve disease. Due to comorbidities and high surgical risk, a substantial number of patients are left untreated. It is especially for these patients that interventional and less invasive devices need to be explored. Most of the currently investigated technologies mimic surgical methods of valvuloplasty, annuloplasty, and valve replacement. Edge-to-edge repair with the MitraClip® device imitates the Alfieri stitch and obtained encouraging results in a randomized trial compared with surgical mitral valve repair. Due to its high safety profile, this approach can already be seen as complimentary to surgery for patients with functional mitral regurgitation and poor left ventricular function. A close interdisciplinary collaboration of cardiologists and cardiac surgeons is essential for a successful interventional mitral valve program.

AB - Surgical mitral valve repair remains the gold standard treatment for significant mitral regurgitation achieving excellent results especially in degenerative mitral valve disease. Due to comorbidities and high surgical risk, a substantial number of patients are left untreated. It is especially for these patients that interventional and less invasive devices need to be explored. Most of the currently investigated technologies mimic surgical methods of valvuloplasty, annuloplasty, and valve replacement. Edge-to-edge repair with the MitraClip® device imitates the Alfieri stitch and obtained encouraging results in a randomized trial compared with surgical mitral valve repair. Due to its high safety profile, this approach can already be seen as complimentary to surgery for patients with functional mitral regurgitation and poor left ventricular function. A close interdisciplinary collaboration of cardiologists and cardiac surgeons is essential for a successful interventional mitral valve program.

KW - Minimally invasive surgical procedures

KW - Mitral valve

KW - Percutaneous

KW - Safety profile

KW - Transcatheter

UR - http://www.scopus.com/inward/record.url?scp=80054100008&partnerID=8YFLogxK

U2 - 10.1007/s00398-011-0876-4

DO - 10.1007/s00398-011-0876-4

M3 - SCORING: Zeitschriftenaufsatz

AN - SCOPUS:80054100008

VL - 25

SP - 258

EP - 265

JO - Z HERZ THORAX GEFASS

JF - Z HERZ THORAX GEFASS

SN - 0930-9225

IS - 5

ER -